Company
United StatesPublic company, NASDAQ: CDNACareDx, Inc. (NASDAQ: CDNA), Brisbane, CA – FDA Inspections
Inspection records and compliance data for CareDx, Inc. in Brisbane, California. 2 FDA inspections on record, last inspected March 28, 2017. Publicly traded as NASDAQ: CDNA.
Company Profile
This profile covers CareDx, Inc. based in Brisbane, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 16, 2014. Last inspected March 28, 2017.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 28, 2017 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1006776 |
| May 16, 2014 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 879159 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
CareDx, Inc.
Stock ticker
CDNA
Exchange
NASDAQ
Share price
$75.99
Market cap
$4.0B
Price as of
November 6, 2026
FEI Number
3005225997
Address
3260 Bayshore Blvd, Brisbane, California 94005, United States
Country
United States
ID: 25da19bf-dc4e-45e3-a08a-e0a96b1fdcc4